Global aHUS Registry Analysis of Patients Switching to Ravulizumab From Eculizumab

CONCLUSION: This is the first real-world cohort analysis of data from patients treated with ravulizumab and reinforces the real-world safety and effectiveness data of ravulizumab in patients with aHUS who switched from …